AVTR
Avantor, Inc.
Healthcare — Medical Instruments & Supplies
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Price History
Fundamentals
| Market Cap | $9.32B |
| P/E Ratio (TTM) | - |
| Forward P/E | 15.63 |
| EPS (TTM) | $-0.84 |
| Dividend Yield | - |
| Profit Margin | -8.81% |
| Revenue Growth | 0.50% |
| ROE | -9.70% |
| Debt/Equity | 65.68 |
| Recommendation | Hold 2.8 |
| Analyst Target | $14.56 |
| Analysts | 14 |
| Next Earnings | Oct 28, 2026 BMO |
| Indexes | - |
Technical Indicators
| RSI (14) | 77.4 |
| Beta | 0.94 |
| SMA 20 | $11.41 |
| SMA 40 | $10.56 |
| 52-Week High | $15.93 |
| 52-Week Low | $7.27 |
| 50-Day Avg | $10.17 |
| 200-Day Avg | $10.23 |
| Avg Volume | $10.62M |
| Volume | $10.84M |
Performance Analysis
NEUTRALAVTR presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Aug 01, 2026 04:14 UTC
Back to Screener Export Report